Methyl 3-(7-methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoate | 1146206-04-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: Methyl 3-(7-methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoate
• 英文别名: methyl 3-(7-methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoate
• CAS: 1146206-04-3
• 化学式: C₁₄H₁₂N₄O₃
• 分子量: 284.274
• InChiKey: BMFNPZYOMSOTCO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  78.6
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  Methyl 3-(7-methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoate 在 lithium hydroxide 、 盐酸 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 生成 3-(7-Methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoic acid
  参考文献：
  名称：

  Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats

  摘要：

  Tricyclic analogues were rationally designed as the high affinity niacin receptor G-protein-coupled receptor 109A (GPR109A) agonists by overlapping three lead structures. Various tricyclic anthranilide and cycloalkene carboxylic acid full agonists were discovered with excellent in vitro activity. Compound 2g displayed a good therapeutic index regarding free fatty acids (FFA) reduction and vasodilation effects in rats, with very weak cytochrome P450 2C8 (CYP2C8) and cytochrome P450 2C9 (CYP2C9) inhibition, and a good mouse pharmacokinetics (PK) profile.

  DOI：

  10.1021/jm900151e
• 作为产物：
  描述：

  7-Methoxytriazolo[1,5-a]quinazoline-3-carbaldehyde 、 三甲基膦酰基乙酸酯 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 生成 Methyl 3-(7-methoxytriazolo[1,5-a]quinazolin-3-yl)prop-2-enoate
  参考文献：
  名称：

  Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats

  摘要：

  Tricyclic analogues were rationally designed as the high affinity niacin receptor G-protein-coupled receptor 109A (GPR109A) agonists by overlapping three lead structures. Various tricyclic anthranilide and cycloalkene carboxylic acid full agonists were discovered with excellent in vitro activity. Compound 2g displayed a good therapeutic index regarding free fatty acids (FFA) reduction and vasodilation effects in rats, with very weak cytochrome P450 2C8 (CYP2C8) and cytochrome P450 2C9 (CYP2C9) inhibition, and a good mouse pharmacokinetics (PK) profile.

  DOI：

  10.1021/jm900151e